Skip to content
Clinical Trials – home
Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Sponsor

Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Spain Passeig De La Vall D'Hebron 119-129, 08035 Barcelona, Spain

About the sponsor

Kidney transplantation, renal graft failure, and solid organ transplantation are central areas of interest, with studies addressing HLA sensitization, immunosuppressive therapy, and Epstein-Barr virus replication in transplant recipients. The sponsor also funds work in hyperimmunized patients and transplant-associated viral control.

  • Kidney transplantation
  • HLA sensitization
  • Epstein-Barr virus
  • Solid organ transplantation
  • Immunosuppressive therapy

These activities reflect a strong focus on post-transplant immune management and infection-related complications in transplant medicine.

About Specializations

Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca runs clinical trials in conditions such as Renal transplant, Type 2 diabetes mellitus, Bacterial infection, Migraine, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

19 clinical trials

Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Amikacin
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Isosorbide Dinitrate
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Camellia Sinensis (Green Tea) Leaf Extract
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Isoniazid
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ivermectin
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cefixime
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Irinotecan
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Indocyanine Green
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ciclosporin
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Maribavir
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Pre-eclampsia

Not yet recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.